Shalaan, O., Daif, A., Elhalfawy, K. (2017). MOLECULAR BASIS OF BETA THALASSEMIA MUTATIONS IN EGYPTIAN PATIENTS. Research Journal of Applied Biotechnology, 3(1), 75-80. doi: 10.21608/rjab.2017.57658
Osama Shalaan; Ahmed Daif; Khalil Elhalfawy. "MOLECULAR BASIS OF BETA THALASSEMIA MUTATIONS IN EGYPTIAN PATIENTS". Research Journal of Applied Biotechnology, 3, 1, 2017, 75-80. doi: 10.21608/rjab.2017.57658
Shalaan, O., Daif, A., Elhalfawy, K. (2017). 'MOLECULAR BASIS OF BETA THALASSEMIA MUTATIONS IN EGYPTIAN PATIENTS', Research Journal of Applied Biotechnology, 3(1), pp. 75-80. doi: 10.21608/rjab.2017.57658
Shalaan, O., Daif, A., Elhalfawy, K. MOLECULAR BASIS OF BETA THALASSEMIA MUTATIONS IN EGYPTIAN PATIENTS. Research Journal of Applied Biotechnology, 2017; 3(1): 75-80. doi: 10.21608/rjab.2017.57658
MOLECULAR BASIS OF BETA THALASSEMIA MUTATIONS IN EGYPTIAN PATIENTS
1Molecular Diagnostics and Therapeutics Department, Genetic Engineering and Biotechnology Research institute (GEBRI), University of Sadat City, Sadat city, Egypt
2Molecular Biology Department, Genetic Engineering and Biotechnology Research institute (GEBRI), University of Sadat City, Sadat city, Egypt
Abstract
Thalassemia is a wide range hereditary disease with high incidence in Egypt along with the high frequency of consanguineous marriages. Investigation the heterogeneity, molecular basis, and natural history are the most effective methods to deal with the thalassemia to develop effective method for management and prevention including the prenatal diagnosis. The current study aims to detect the most common β -globin gene mutations in Egypt among β-thalassemic patients by using PCR based reverse hybridization method (StripAssay) for the most prevalent 22 β-globin gene mutations in the mediterranean population in an attempt to estimate the incidence of each mutation, and an attempt to improve our control strategy of β- thalassemia. This study included a total of 37 confirmed β- thalassemia ethnic Egyptian patients (23 males and 14 females) out of them 17 patients were a thalassemia major and 20 were a thalassemia intermediate. Evaluation of β-thalassemia mutations revealed that, the presence of 9 different β-globin mutations. The most frequent mutation were IVS 1-110[34%], IVS 1-6(23.5%), IVS 1-1(19%), Codon 27[6.5%], IVS 2-848[6.5%], IVS 2-745[2.1%] and IVS 2.1 [2.5%], Codon 39[4%]), and IVS 1.5 [1.5%]. IVS 1-110[G>A] is the commonest homozygous mutation found in 6 out of 14 homozygous cases accounting for about 43% of homozygous mutations while, IVS 1-110[G>A]/ IVS 1-6[T>C] is the commonest heterozygous mutation found in 6 out of 23 heterozygous cases accounting for about 26% of heterozygous mutations . In conclusion,β-Globin Strip Assay is useful rapid screening method for β-globin gene mutations which can provide an insight into the detection of individual patients, to take the proper measurement, and thus could be used as a basis for genetic counseling and prenatal diagnosis.
View on SCiNiTO
Top